imatinib mesylate has been researched along with Angiitis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nagashima, H; Nakamura, Y; Sasaki, N; Sawai, T; Suzuki, N; Utsumi, Y; Yamashita, M; Yamauchi, K | 1 |
Bloomfield, K; Braunschweig, I; Chadburn, A; Darji, J; Gotlib, V; Patel, A | 1 |
Gross, WL; Hellmich, B; Holl-Ulrich, K | 1 |
Birck, R; Hochhaus, A; Kälsch, AI; Schmitt, WH; Soboletzki, M; van der Woude, FJ; Yard, BA | 1 |
2 review(s) available for imatinib mesylate and Angiitis
Article | Year |
---|---|
Eosinophilic variant of chronic myeloid leukemia with vascular complications.
Topics: Adult; Anticoagulants; Antineoplastic Agents; Benzamides; Bone Marrow; Diagnostic Errors; Eosinophilia; Fingers; Gangrene; Humans; Imatinib Mesylate; Leg; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Pain; Piperazines; Pyrimidines; Radiography; Vasculitis; Vitamins | 2003 |
[Hypereosinophilic syndrome--recent developments in diagnosis and treatment].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Glucocorticoids; Humans; Hypereosinophilic Syndrome; Hypersensitivity; Imatinib Mesylate; Immunosuppressive Agents; Interferon-alpha; Lung Diseases; Neoplasms; Parasitic Diseases; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Tumor Necrosis Factor-alpha; Vasculitis | 2007 |
2 other study(ies) available for imatinib mesylate and Angiitis
Article | Year |
---|---|
Effects of imatinib mesylate on pulmonary allergic vasculitis in a murine model.
Topics: Administration, Inhalation; Administration, Oral; Animals; Benzamides; Bronchoalveolar Lavage Fluid; Cell Proliferation; Comorbidity; Cytokines; Disease Models, Animal; Eosinophils; Female; Imatinib Mesylate; Mice; Mice, Inbred C57BL; Myofibroblasts; Ovalbumin; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Respiratory Hypersensitivity; Vasculitis | 2013 |
Imatinib mesylate, a new kid on the block for the treatment of anti-neutrophil cytoplasmic autoantibodies-associated vasculitis?
Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Autoimmune Diseases; Benzamides; Cell Proliferation; Cells, Cultured; Culture Media, Conditioned; Cytokines; Drug Evaluation, Preclinical; Endothelium, Vascular; Granulomatosis with Polyangiitis; HLA-DR Antigens; Humans; Imatinib Mesylate; Lymphocyte Activation; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines; T-Lymphocytes; Vasculitis | 2008 |